Last summer, Project CBD helped recruit subjects for a large-scale clinical study to assess the safety and efficacy of the daily use of cannabidiol. Good news: Contrary to FDA warnings, preliminary results of the ValidCare study show “no clinical evidence of liver disease in any of the participants.”
Not only is there little evidence that cannabidiol plays a role in damaging the liver, CBD may help to improve liver health.
Another study indicates that cannabis may not be harmful to patients undergoing organ transplants.
Project CBD seeks volunteers to assess the safety and efficacy of cannabidiol.
The huge popularity of cannabidiol (CBD), a non-intoxicating component of cannabis, has helped to destigmatize the plant and restore its reputation as an important medicinal herb.